/Investor DB

Hillhouse Investment — 2026 Investments

3 investments dated 2026 · listed companies and verified rows first · show all

Axoftaxoft.usinApr 2026 · $55M

Axoft is developing soft, tissue-mimicking neural implants and supporting bidirectional electronics that record and stimulate brain activity through a minimally-invasive burr-hole procedure.

AI & Machine LearningDeep TechMedical DevicesCambridge, US

Paul Le Floch(Executive Officer, Director)inTianyang Ye(Director)inRachel Sha(Director)in

BoardChia An Lee(Director)Benjamin Pless(Director)

Co-investorsAlumni VenturesAmino CapitalArcherman CapitalBlindspot Ventures Management CoCastor VenturesCreative Destruction Lab (CDL)+4 more

Quest Globalquestglobal.comin𝕏Feb 2026

Quest Global offers end-to-end Product Lifecycle Management (PLM) and digitization services for engineering companies, leveraging AI and low-code technologies to optimize product development from concept through operations.

Advanced ManufacturingAI & Machine LearningDeep TechEnterprise SoftwareHardwareIoT

Tinku Malayil Jose(Head of Technology Office, Hi-Tech)in

Co-investorsChrysCapitalAdvent InternationalBain CapitalCarlyle GroupGIC

Third Arc Biothirdarcbio.cominFeb 2026

Third Arc Bio develops breakthrough treatments in oncology and immunology through advanced biologics engineering.

BiotechMedical DevicesLower Gwynedd, US

Joseph Erhardt(Executive Officer)inPeter Lebowitz(Executive Officer, Director)

BoardArjun Goyal(Director)inOtello Stampacchia(Director)inFrancesco Draetta(Director)in

Co-investorsAndreessen HorowitzVida VenturesBiotechnology Value FundForesite CapitalOmega FundsT. Rowe Price

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.